← Back to news

Markets

Dollar gains against peers after Powell's cautious rate outlook

Y

FTX Recovery Trust Sues Genesis Digital to Recover $1.15 Billion

Y

Keurig Dr Pepper Moves to Acquire JDE Peet’s While Planning Company Split and Sustaining Dividend

Y

Exxon Mobil Boosts Q2 Performance While Acquiring Superior Graphite and Strengthening Dividend

Y

Coterra Energy Reports Strong Q2 Growth Despite Lowered Price Targets and Boosts Dividend Appeal

Y

Phillips 66 Expands Refining Capacity and Strengthens Dividend Outlook Following Q2 Beat

Y

Merck Gains FDA Approval for KEYTRUDA QLEX and Supports Dividend Appeal

Y

Chevron Advances with Hess Acquisition and Divestiture Plans While Maintaining Dividend Appeal

Y

Pfizer Raises EPS Guidance and Expands Cost-Cutting Plan While Boosting Dividend Appeal

Y

Ray Dalio Warns Of 'Very, Very Dark Times,' Says Learning To 'Diversify My Bets' Was The Key To Success: 'A Smart Rabbit Has Three Holes'

Y

Wall Street Is Eating Up This Dividend Stock. Should You Buy Shares Before They Surge as Much as 30%?

Y

These 3 Dividend Stocks Just Raised Their Payouts by Double Digits

Y

Stablecoin Titan Tether Seeks $500 Billion Valuation on $20 Billion Raise: Report

Y

Hoth Therapeutics, Inc. (HOTH) Files EMA Application for Global Expansion of HT-001 Skin Therapy

Y

Invivyd, Inc. (IVVD) Secures FDA Path for COVID-19 Antibody Approval

Y

Entero Therapeutics, Inc. (ENTO) Names Jason D. Sawyer as New CEO Amid Strategic Shift

Y

Relmada Therapeutics, Inc. (RLMD) Advances Oncology and CNS Therapies with Promising Phase 2 Data

Y

Tiziana Life Sciences Ltd (TLSA) Secures U.S. DoD Grant to Advance Intranasal Foralumab for Spinal Cord Injury

Y

NovaBay Pharmaceuticals, Inc. (NBY) Declares $0.80 Special Dividend, Boosting Shareholder Value

Y

Lineage Cell Therapeutics, Inc. (LCTX) Shows Vision Gains in Phase 1/2a OpRegen Trial

Y

Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization

Y

Gossamer Bio, Inc. (GOSS) Stock Jumps 18% on FDA Updates and Seralutinib Progress

Y

Matinas BioPharma Holdings, Inc. (MTNB) Restructures Amid Challenges, Focuses on Oral Antifungal MAT2203

Y

Galectin Therapeutics Inc. (GALT) Surges on Promising Belapectin Trial Data and Strong Financials

Y

Atai Life Sciences N.V. (ATAI) Advances Psychedelic Therapies for Mental Health, Drawing Investor Spotlight

Y

MindWalk Holdings Corp. (HYFT) Surges with 45% Revenue Growth and Strategic AI-Focused Rebrand

Y

I-Mab (IMAB) Shows 83% Response Rate for Givastomig in Metastatic Gastric Cancer

Y

ABVC BioPharma, Inc. (ABVC) Reports 103% Asset Surge, Eyeing Phase III Trials for Depression Therapies

Y

Jazz Pharmaceuticals plc (JAZZ) Advances Rare Cancer Portfolio with First CNS Glioma Therapy Approval

Y

Elanco Animal Health Incorporated (ELAN) Joins S&P MidCap 400 Following Strong Q2 Growth and Product Ramp-Up

Y

Royalty Pharma plc (RPRX) Completes $2B Senior Notes Offering, Strengthens Capital for Growth

Y

Viatris Inc. (VTRS) Gains FDA Approval for First Generic Iron Sucrose Injection

Y

Pfizer Inc. (PFE) Targets $4.5B in Cost Savings to Fuel R&D and Innovative Therapies

Y

Powering AI: From CERA Week Optimism to New York Climate Week Realism

Y

Stock market today: Nasdaq, S&P 500 futures pop while Dow holds steady as Alibaba spreads AI cheer

Y

Stock market today: Nasdaq, Dow, S&P 500 waver with divided Fed, Alibaba in focus

Y

Stock market today: Nasdaq, Dow, S&P 500 rise as Alibaba spreads AI cheer

Y

Stock market today: Nasdaq, Dow, S&P 500 fall with divided Fed, Alibaba in focus

Y

Stock market today: Dow, S&P 500, Nasdaq futures edge up after Wall Street's record-setting rally stalls

Y

EMA Gives Positive Opinion on Zoetis Inc. (ZTS)’ Cat Arthritis Therapy, Portela

Y

Merck & Co., Inc. (MRK) Received FDA Approval For Keytruda Qlex, Cutting Infusion Time to 2 Minutes

Y

Why Crane NXT Stock Surged by 15% Today

Y

Bristol-Myers Squibb Company (BMY) to Divest 60% China JV Amid Strategic Realignment

Y

Johnson & Johnson (JNJ) Gains FDA Nod for Subcutaneous Tremfya in Ulcerative Colitis

Y

Eli Lilly and Company (LLY) Unveils $5B Virginia Facility to Ramp Up Bioconjugate and Monoclonal Antibody Production

Y

Retirement Fear Is Real: 64% Worry More About Running Out Of Money Than Death Itself

Y

Is Iraq Looking To Open Another Backdoor For Iran To Export Its Oil?

Y

Why HeartFlow Stock Rocketed 14% Higher Today

Y

Micron's Q4 earnings surpass Wall Street's expectations in latest test of AI trade

Y

Why Intel Stock Drifted Higher Today

Y